PXMD — PaxMedica Balance Sheet
0.000.00%
- $0.01m
- -$0.31m
Annual balance sheet for PaxMedica, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.025 | 1.12 | 0.444 | 1.9 | 4.71 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | — | — | 0 |
Prepaid Expenses | |||||
Total Current Assets | 0.025 | 1.12 | 0.444 | 2.2 | 5.68 |
Other Long Term Assets | |||||
Total Assets | 0.025 | 1.12 | 0.649 | 2.2 | 5.68 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.123 | 5.75 | 10.8 | 2.1 | 1.8 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.123 | 5.75 | 10.8 | 2.1 | 2.3 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -0.098 | -4.63 | -10.1 | 0.109 | 3.39 |
Total Liabilities & Shareholders' Equity | 0.025 | 1.12 | 0.649 | 2.2 | 5.68 |
Total Common Shares Outstanding |